Grant: Idea to Innovation
McGill University
$124,827.00
Graphite calorimeter probe for clinical radiation dosimetry
EF 2016-17
Résumé
This Idea-to-Innovation proposal builds on patent-pending probe calorimeter-based technology to take significant steps to bring to market a revolutionary new, self-calibrating radiation dosimeter system. This system is useful in clinical reference determination of delivered dose in the medical application of radiation to the treatment of cancer of radiation therapy units as well as in other applications involving the accurate measurement of ionizing radiation dose. The proposal aims to refine the design and manufacturing quality of the detector system, will have the system undergo third-party validation and will provide a foundation to establish and incorporate a start-up company, called Caldose. Caldose will be the first company to make available a self-calibrating dosimetry system for applications in radiation therapy clinics, dose calibration laboratories, as well as other irradiation facilities (food processing, nuclear medicine, radiobiology, medical sterilization, security services, etc.). Since current dose measurement systems rely on calibration coefficients obtained from a primary standards dose laboratory, their accurate use is limited to a particular set of standard conditions. Any use of these devices that deviates from these calibration conditions (e.g., a realistic patient setup) must be correctly accounted, which often leads to significant uncertainty on the measured dose. Our patent-pending technology is based on calorimetric concepts that have been established over the last 60 years by standards dosimetry labs, and offers the most direct means of measuring the delivered dose at the point of care.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
500180-2016
Name nom
Seuntjens, Jan
Department département
Oncology
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
124827
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3115
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Medical Physics
Research subject fr
Physique médicale
Partie
1
Nb partie
1
Application title
Graphite calorimeter probe for clinical radiation dosimetry
Keyword
NSERC
Application summary
This Idea-to-Innovation proposal builds on patent-pending probe calorimeter-based technology to take significant steps to bring to market a revolutionary new, self-calibrating radiation dosimeter system. This system is useful in clinical reference determination of delivered dose in the medical application of radiation to the treatment of cancer of radiation therapy units as well as in other applications involving the accurate measurement of ionizing radiation dose. The proposal aims to refine the design and manufacturing quality of the detector system, will have the system undergo third-party validation and will provide a foundation to establish and incorporate a start-up company, called Caldose. Caldose will be the first company to make available a self-calibrating dosimetry system for applications in radiation therapy clinics, dose calibration laboratories, as well as other irradiation facilities (food processing, nuclear medicine, radiobiology, medical sterilization, security services, etc.). Since current dose measurement systems rely on calibration coefficients obtained from a primary standards dose laboratory, their accurate use is limited to a particular set of standard conditions. Any use of these devices that deviates from these calibration conditions (e.g., a realistic patient setup) must be correctly accounted, which often leads to significant uncertainty on the measured dose. Our patent-pending technology is based on calorimetric concepts that have been established over the last 60 years by standards dosimetry labs, and offers the most direct means of measuring the delivered dose at the point of care.